Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics of endocrine therapy in breast cancer.

Journal of human genetics - 1 Jun 2013

Ingle James N

Abstract excerpt

The most important modality of treatment in the two-thirds of patients with an estrogen receptor (ER)-positive early breast cancer is endocrine therapy. In postmenopausal women, options include the selective ER modulators (SERMs), tamoxifen and raloxifene, and the 'third-generation' aromatase inhibitors (AIs), anastrozole, exemestane and letrozole. Under the auspices of the National Institutes of Health Global...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androstadienes
Share to Antineoplastic Agents, Hormonal
Share to Aromatase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Nitriles

Share to Selective Estrogen Receptor Modulators

Share to Tamoxifen

Share to Triazoles

Source

Open in PubMed Open full text

Identifiers

PMID: 23635953
DOI: 10.1038/jhg.2013.35
PMCID: PMC3926210

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics of endocrine therapy in breast cancer.PMID 23635953Read ↗

Molecular Changes During Breast Cancer and Mechanisms of Endocrine Therapy Resistance.Semantic proximity Read ↗

An “Omics” Approach to Determine the Mechanisms of Acquired Aromatase Inhibitor ResistanceSemantic proximity Read ↗

Pharmacogenomics of third-generation aromatase inhibitors.Semantic proximity Read ↗

Pharmacogenomics of breast cancer therapy: An updateSemantic proximity Read ↗

Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy ResistanceSemantic proximity Read ↗

Endocrine-related resources from the National Institutes of Health.Semantic proximity Read ↗

Estrogen Receptor Signaling in Breast CancerSemantic proximity Read ↗

Molecular biology of the estrogen receptor aids in the understanding of tamoxifen resistance and breast cancer prevention with raloxifene.Semantic proximity Read ↗

The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.Semantic proximity Read ↗

Pharmacogenomics of endocrine therapy in breast cancer.Semantic proximity Read ↗

Molecular mechanism of estrogen–estrogen receptor signalingSemantic proximity Read ↗

Functional and physiological genomics of estrogen-related receptors (ERRs) in health and diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.